Rituximab monotherapy in mild pemphigus
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
The Journal of dermatological treatment - 33(2022), 3 vom: 04. Mai, Seite 1784-1786 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nili, Ali [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 25.08.2022 Date Revised 30.08.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09546634.2020.1836309 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316105341 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316105341 | ||
003 | DE-627 | ||
005 | 20231225160349.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09546634.2020.1836309 |2 doi | |
028 | 5 | 2 | |a pubmed24n1053.xml |
035 | |a (DE-627)NLM316105341 | ||
035 | |a (NLM)33040641 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nili, Ali |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rituximab monotherapy in mild pemphigus |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.08.2022 | ||
500 | |a Date Revised 30.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a Rituximab |2 NLM | |
650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
700 | 1 | |a Mahmoudi, Hamidreza |e verfasserin |4 aut | |
700 | 1 | |a Heidari, Nikta |e verfasserin |4 aut | |
700 | 1 | |a Tavakolpour, Soheil |e verfasserin |4 aut | |
700 | 1 | |a Salehi Farid, Ali |e verfasserin |4 aut | |
700 | 1 | |a Balighi, Kamran |e verfasserin |4 aut | |
700 | 1 | |a Daneshpazhooh, Maryam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of dermatological treatment |d 1992 |g 33(2022), 3 vom: 04. Mai, Seite 1784-1786 |w (DE-627)NLM088851680 |x 1471-1753 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2022 |g number:3 |g day:04 |g month:05 |g pages:1784-1786 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09546634.2020.1836309 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2022 |e 3 |b 04 |c 05 |h 1784-1786 |